ChemoCentryx Inc.

ChemoCentryx Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
50.38 M
Public Float
24.94 M
ChemoCentryx Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.8
Market Cap
$516.05 M
Shares Outstanding
58.05 M
Public Float
30.54 M

Profile

Address
850 Maude Avenue
Mountain View California 94043
United States
Employees -
Website http://www.chemocentryx.com
Updated 07/08/2019
ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact.

Financials

View All

Thomas J. Schall
Chairman, President & Chief Executive Officer
Henry K. McKinnell
Independent Director